Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine monotherapy in children.

T F Barron1, S L Hunt, T F Hoban

  • 1Section of Pediatric Neurology, Department of Pediatrics, M.S. Hershey Medical Center, Pennsylvania State University, College of Medicine;, Hershey, Pennsylvania, USA.

Pediatric Neurology
|October 6, 2000
PubMed
Summary

Lamotrigine effectively treats pediatric epilepsy, with 45% of children becoming seizure-free. This epilepsy medication shows promise as a first-line treatment option for both focal and generalized seizures in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study).

Vaccine·2023
Same author

Concussion symptoms experienced during driving may influence driving habits.

Brain injury·2020
Same author

Reflective debrief and the social space: offload, refuel, and stay on course.

Clinical radiology·2020
Same author

A Pilot Study on Adolescents With Depression and Insomnia: Qualitative Findings From Focus Groups.

Behavioral sleep medicine·2015
Same author

Symmetrical defects in the lower lids associated with abnormalities of the zygomatic processes of the temporal bone.

American journal of ophthalmology·2010
Same author

Symmetric defects in the lower lids associated with abnormalities of the zygomatic processes of the temporal bones.

Archives of ophthalmology (Chicago, Ill. : 1929)·2010

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy affects a significant number of children worldwide.
  • Monotherapy is often preferred for managing pediatric epilepsy to minimize polypharmacy.
  • Lamotrigine is an established antiepileptic drug with a known safety profile.

Purpose of the Study:

  • To retrospectively evaluate the effectiveness of lamotrigine as a monotherapeutic agent in pediatric epilepsy.
  • To assess treatment response in children with focal versus generalized epilepsy.
  • To determine the efficacy in both antiepileptic drug-naive and drug-exposed pediatric populations.

Main Methods:

  • Retrospective review of 83 pediatric patients with epilepsy treated with lamotrigine monotherapy.
  • Patients categorized by epilepsy type (focal vs. generalized) and prior drug exposure.

Related Experiment Videos

  • Data collected included dosages, side effects, follow-up duration, and seizure control (defined as seizure-free for ≥6 months).

    • Main Results:

    • Overall, 45% of pediatric patients achieved seizure freedom for 6 months or more.
    • Efficacy was observed in both focal epilepsy (44% seizure-free) and generalized epilepsy (36% seizure-free).
    • Rash was the most common side effect (6%), with no cases of Stevens-Johnson syndrome reported.

    Conclusions:

    • Lamotrigine demonstrates effectiveness as a monotherapeutic agent for various pediatric epilepsies, including focal and generalized types.
    • The drug is generally well-tolerated, with a low incidence of significant side effects.
    • Lamotrigine may be a suitable and effective first-line treatment option for pediatric epilepsy.